Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Cash from Investing Activities Growth (3y) (2013 - 2026)

Analysis

Emergent BioSolutions (EBS) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 33.51%
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn -51.98%
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn 21.19%
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn -47.89%
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn 27.70%
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn -69.92%
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn -
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn -39.73%
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn -30.12%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -30.12%
Mar 31, 2026 45.83%
Dec 31, 2025 55.88%
Sep 30, 2025 76.78%
Jun 30, 2025 36.37%
Mar 31, 2025 56.70%
Dec 31, 2024 37.94%
Sep 30, 2024 59.12%
Jun 30, 2024 59.05%
Mar 31, 2024 42.26%
Dec 31, 2023 32.40%
Sep 30, 2023 25.50%
Jun 30, 2023 97.59%
Mar 31, 2023 14.55%
Dec 31, 2022 -7.94%
Sep 30, 2022 -160.86%
Jun 30, 2022 -10.03%
Mar 31, 2022 -14.59%
Dec 31, 2021 62.21%
Sep 30, 2021 -28.36%
API Access

Emergent BioSolutions Cash from Investing Activities Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities-growth-3y&ticker=EBS&period=max&api_key=YOUR_API_KEY